Effect of ranitidine and indomethacin on nocturnal gastric acidity in normal subjects

SUMMARY To assess the effect of indomethacin on gastric acidity and to identify a potential pharmacodynamic interaction between indomethacin and ranitidine, we measured nocturnal acidity on half-hourly aliquots of gastric contents from 10 volunteers on the seveneth day of four dosing regimens given in a randomized double-blind manner. These were indomethacin (50 mg t.d.s.) and ranitidine (300 mg in the evening) together or alone with matching placebos. Median nocturnal acidity on placebo was 41.7 mmol/L (range 67.6–25.1 mmol/L) and was 39.8 mmol/L (63.1–24.0 mmol/L) on indomethacin (N.S.). During ranitidine dosing it was 0.4 mmol/L (21.3–0.0 mmol/L) without and 0.8 mmol/L (43.7–0.0 mmol/L) with concurrent indomethacin, representing 99 and 98% decreases in gastric acidity (P < 0.01) compared with placebo. Indomethacin did not increase overnight gastric acidity and did not influence the suppression of acidity produced by ranitidine. It is unlikely that the ulcerogenic potential of indomethacin is explicable by an effect on gastric acidity.